Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.
About
Alto Neuroscience is a clinical-stage biopharmaceutical company focused on developing a new generation of precision psychiatry medicines. They use an AI-enabled platform to identify and validate brain-based biomarkers, aiming to match patients with the right Alto drug candidate for depression, PTSD, and other mental health disorders. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Alto Neuroscience do?
Alto Neuroscience is a Biotech company that offers Platform. Teams look it up for MedTech, HealthTech, Drug Discovery. It is based in Los Altos, United States and was founded in 2019. Public records show about 86 people and $370M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Alto Neuroscience raised?
Alto Neuroscience has raised a total of $370M in funding. The most recent round on record is Registered Direct Offering.
Where is Alto Neuroscience headquartered?
Alto Neuroscience is headquartered in Los Altos, United States.
When was Alto Neuroscience founded?
Alto Neuroscience was founded in 2019.
What industry does Alto Neuroscience operate in?
Alto Neuroscience operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
How many employees does Alto Neuroscience have?
Alto Neuroscience has approximately 86 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.